In Part 1, Prof. Arun Sanyal (Virginia Commonwealth University, Richmond, VA, USA) speaks to us about the mechanism of action of icosabutate, a novel engineered fatty acid currently under investigation in NASH. He continues this conversation in Part 2 where we discuss the results from the interim analysis of the ICONA trial (NCT04052516). His abstract […]